Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes.

[1]  N. Kelekis,et al.  Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Impact of Tumor Size on the Progression Survival Rates , 2021, Diagnostics.

[2]  Sam S. Chang,et al.  Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I , 2021, The Journal of urology.

[3]  X. Cathelineau,et al.  Optimal Surgical Outcome of Minimally Invasive Partial Nephrectomy (MIPN) Based on an Early Postoperative Estimated Glomerular Filtration Rate (eGFR) , 2021, Current Urology Reports.

[4]  U. Capitanio,et al.  Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass. , 2021, European urology.

[5]  L. Solbiati,et al.  Real-Time US-CT fusion imaging for guidance of thermal ablation in of renal tumors invisible or poorly visible with US: results in 97 cases , 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[6]  R. Arellano,et al.  Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety. , 2020, Journal of endourology.

[7]  F. Orsi,et al.  Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral Center , 2020, Cancers.

[8]  S. Bhayani,et al.  Ten-Year Experience with Percutaneous Cryoablation of Renal Tumors: Tumor Size Predicts Disease Progression. , 2020, Journal of endourology.

[9]  P. Liang,et al.  Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients. , 2020, Radiology.

[10]  J. Cheville,et al.  Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. , 2019, European urology.

[11]  S. Rais-Bahrami,et al.  Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes , 2019, CardioVascular and Interventional Radiology.

[12]  S. Nakada,et al.  Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated with either Percutaneous Microwave Ablation or Surgery. , 2019, Urology.

[13]  C. Porta,et al.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  R. Thompson,et al.  Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned. , 2018, AJR. American journal of roentgenology.

[15]  M. Liss,et al.  Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. , 2018, Journal of vascular and interventional radiology : JVIR.

[16]  F. Orsi,et al.  Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation , 2017, Insights into Imaging.

[17]  S. Boorjian,et al.  Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes. , 2015, Journal of vascular and interventional radiology : JVIR.

[18]  S. Boorjian,et al.  Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. , 2015, Journal of vascular and interventional radiology : JVIR.

[19]  J. Cheville,et al.  Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. , 2015, European urology.

[20]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[21]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.

[22]  K. Katsanos,et al.  Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours , 2014, CardioVascular and Interventional Radiology.

[23]  Jie Cai,et al.  "Trifecta" in partial nephrectomy. , 2013, The Journal of urology.

[24]  Samuel K. Park,et al.  Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. , 2012, European urology.

[25]  Samuel K. Park,et al.  Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. , 2012, The Journal of urology.

[26]  B. Leibovich,et al.  Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. , 2010, Journal of endourology.

[27]  Walter Artibani,et al.  Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. , 2009, European urology.

[28]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[29]  K. Takeda,et al.  Radiofrequency Ablation Combined with Renal Arterial Embolization for the Treatment of Unresectable Renal Cell Carcinoma Larger Than 3.5 cm: Initial Experience , 2006, CardioVascular and Interventional Radiology.

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.